Osaic Holdings’s Day One Biopharmaceuticals DAWN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-32,873
Closed -$705K – 8041
2026
Q1
$705K Sell
32,873
-6,617
-17% -$93.2K ﹤0.01% 3175
2025
Q4
$368K Buy
39,490
+2,195
+6% +$18.3K ﹤0.01% 3612
2025
Q3
$261K Hold
37,295
– – ﹤0.01% 3996
2025
Q2
$214K Sell
32,881
-32,430
-50% -$223K ﹤0.01% 3883
2025
Q1
$518K Buy
65,311
+32,459
+99% +$350K ﹤0.01% 2840
2024
Q4
$416K Buy
32,852
+32,421
+7,522% +$451K ﹤0.01% 2959
2024
Q3
$6K Buy
431
+263
+157% +$3.75K ﹤0.01% 6113
2024
Q2
$2.32K Buy
+168
New +$2.46K ﹤0.01% 6542
2023
Q4
– Sell
-24
Closed -$294 – 7339
2023
Q3
$294 Buy
24
+10
+71% +$130 ﹤0.01% 7089
2023
Q2
$167 Sell
14
-169
-92% -$2.21K ﹤0.01% 7234
2023
Q1
$2.44K Buy
+183
New +$3.58K ﹤0.01% 6632
2022
Q3
– Sell
-1
Closed – – 7297
2022
Q2
$0 Buy
+1
New – ﹤0.01% 7392

Other funds holding DAWN

Osaic Holdings's DAWN Position: Q2 2026 in Review

Osaic Holdings sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 32,873 shares — an estimated $705K sold.

Osaic Holdings first reported a position in DAWN in Q2 2022 and held it in 12 quarters. The position peaked at $705K in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

  • Osaic Holdings reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Osaic Holdings sold 32,873 Day One Biopharmaceuticals shares in Q2 2026, an estimated $705K.
  • Osaic Holdings first reported a position in Day One Biopharmaceuticals in Q2 2022 and held it in 12 quarters.
  • Osaic Holdings's Day One Biopharmaceuticals position peaked at $705K in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.